Importance of Biomarker Testing in Patients with NSCLC

Two experts discuss the evolving treatment landscape for patients with non-small cell lung cancer (NSCLC) and reviews the role of molecular testing and discusses some of the challenges faced.

Read the full article here

Related Articles